Antimicrobial peptide-mediated bacterial membrane disruption (null)

Molecular Classification

Other (peptide-based mechanism)

Other Names

Antimicrobial peptides (AMPs), tdAMP-1, tdAMP-2, tomato-derived antimicrobial peptides

Disease Roles

Infection (specifically Gram-negative bacterial infections such as Salmonella Typhi and Escherichia coli)

Antimicrobial peptide-mediated bacterial membrane disruption Overview

The entry "Bacterial membrane disruption by antimicrobial peptides tdAMP-1/tdAMP-2 against Gram-negative bacteria including Salmonella Typhi/E coli" does not refer to a single canonical molecular target such as a receptor, enzyme, or transporter. Instead, it describes the general mechanism of action for a class of molecules—antimicrobial peptides (AMPs), specifically tomato-derived AMPs named tdAMP-1 and tdAMP-2. These peptides exert their antibacterial effects primarily by disrupting the integrity of the bacterial cell membrane, leading to leakage of cellular contents and rapid bacterial death[6]. This is considered a broad biophysical effect rather than interaction with a discrete molecular target. Some AMPs can also enter cells and interfere with intracellular processes like protein synthesis or nucleic acid function; however, for most Trp/Arg-rich AMPs—including those similar in structure to tdAMPs—the primary mode is membrane permeabilization[1][3]. There is no evidence that these particular AMPs act on specific receptors or enzymes within bacteria. Because this entry refers to an action/mechanism rather than an individual molecule/receptor/protein that could be targeted by drugs in the conventional sense, it should be marked as incorrect for structured drug-target databases. The correct approach would be to list each AMP individually if needed ("Tomato-derived antimicrobial peptide 1", "Tomato-derived antimicrobial peptide 2") but not "bacterial membrane disruption" itself as a target. These tdAMPs have demonstrated potent antimicrobial properties by effectively disrupting bacterial membranes. The efficacy of tdAMP‑2 is shown... [6] Tryptophan‑ and arginine‑rich AMPs interact strongly with negatively charged components in Gram‑negative outer membranes; their main function is direct permeabilization/disruption rather than binding specific proteins.[1][3] In summary: this entry describes an antibacterial mechanism mediated by certain peptides—not a canonical druggable biological target—and should not be treated as such in structured data systems.

Mechanism of Action

Disruption of bacterial cell membranes leading to cell death[6]

Biological Functions

Bacterial cell membrane disruption

Inhibition of protein synthesis

Disease Associations

Infection (specifically Gram-negative bacterial infections such as Salmonella Typhi and Escherichia coli)

Safety Considerations

Potential cytotoxicity to host cells at high concentrations or with non-selective AMPs[1][3]

Interacting Drugs

None (tdAMPs themselves are investigational agents/peptides, not drugs targeting a specific molecular target)

Associated Biomarkers

Biomarker
None known